These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34090251)

  • 21. Cannabis use disorder and dissociation: A report from a prospective first-episode psychosis study.
    Ricci V; Ceci F; Di Carlo F; Lalli A; Ciavoni L; Mosca A; Sepede G; Salone A; Quattrone D; Fraticelli S; Maina G; Martinotti G
    Drug Alcohol Depend; 2021 Dec; 229(Pt A):109118. PubMed ID: 34688166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use.
    Ferraro L; La Cascia C; Quattrone D; Sideli L; Matranga D; Capuccio V; Tripoli G; Gayer-Anderson C; Morgan C; Sami MB; Sham P; de Haan L; Velthorst E; Jongsma HE; Kirkbride JB; Rutten BPF; Richards AL; Roldan L; Arango C; Bernardo M; Bobes J; Sanjuan J; Santos JL; Arrojo M; Tarricone I; Tortelli A; Szöke A; Del-Ben CM; Selten JP; Lynskey M; Jones PB; Van Os J; La Barbera D; ; Murray RM; Di Forti M
    Schizophr Bull; 2020 Apr; 46(3):517-529. PubMed ID: 31361020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depressive symptoms and their relationship with negative and other psychotic symptoms in early onset psychosis.
    Calderon-Mediavilla M; Vila-Badia R; Dolz M; Butjosa A; Barajas A; Del Cacho N; Sánchez B; Pardo M; Baños I; Usall J; Ochoa S; ;
    Eur Child Adolesc Psychiatry; 2021 Sep; 30(9):1383-1390. PubMed ID: 32865655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between cannabis and psychosis: Reasons for use and associated clinical variables.
    Mané A; Fernández-Expósito M; Bergé D; Gómez-Pérez L; Sabaté A; Toll A; Diaz L; Diez-Aja C; Perez V
    Psychiatry Res; 2015 Sep; 229(1-2):70-4. PubMed ID: 26235479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
    Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabis use in patients with a first psychotic episode and subjects at ultra high risk of psychosis: impact on psychotic- and pre-psychotic symptoms.
    Machielsen M; van der Sluis S; de Haan L
    Aust N Z J Psychiatry; 2010 Aug; 44(8):721-8. PubMed ID: 20636193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Negative symptoms in children and adolescents with early-onset psychosis and at clinical high-risk for psychosis: systematic review and meta-analysis.
    Salazar de Pablo G; Catalan A; Vaquerizo Serrano J; Pedruzo B; Alameda L; Sandroni V; Armendariz A; Rodriguez V; Arango C; Moreno C; Downs J; Abbott C; Shin JI; Solmi M; Fusar-Poli P; Correll CU
    Br J Psychiatry; 2023 Jul; 223(1):282-294. PubMed ID: 37194556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabis use and transition to psychosis in people at ultra-high risk.
    Valmaggia LR; Day FL; Jones C; Bissoli S; Pugh C; Hall D; Bhattacharyya S; Howes O; Stone J; Fusar-Poli P; Byrne M; McGuire PK
    Psychol Med; 2014 Sep; 44(12):2503-12. PubMed ID: 25055169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basic symptoms in the general population and in psychotic and non-psychotic psychiatric adolescents.
    Meng H; Schimmelmann BG; Koch E; Bailey B; Parzer P; Günter M; Mohler B; Kunz N; Schulte-Markwort M; Felder W; Zollinger R; Bürgin D; Resch F
    Schizophr Res; 2009 Jun; 111(1-3):32-8. PubMed ID: 19321309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age of onset of Cannabis use and cognitive function in first-episode non-affective psychosis patients: Outcome at three-year follow-up.
    Setién-Suero E; Martínez-García O; de la Foz VO; Vázquez-Bourgon J; Correa-Ghisays P; Ferro A; Crespo-Facorro B; Ayesa-Arriola R
    Schizophr Res; 2018 Nov; 201():159-166. PubMed ID: 29861266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smoking status and its relationship to demographic and clinical characteristics in first episode psychosis.
    Grossman M; Bowie CR; Lepage M; Malla AK; Joober R; Iyer SN
    J Psychiatr Res; 2017 Feb; 85():83-90. PubMed ID: 27863280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use.
    Ruiz-Veguilla M; Gurpegui M; Barrigón ML; Ferrín M; Marín E; Rubio JL; Gutiérrez B; Pintor A; Cervilla J
    Schizophr Res; 2009 Feb; 107(2-3):158-64. PubMed ID: 18805673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of onset age on the long-term outcome of early-onset psychoses and other mental disorders: a register-based Northern Finland Birth Cohort 1986 study.
    Majuri T; Haapea M; Nordström T; Säynäjäkangas V; Moilanen K; Tolonen J; Ala-Mursula L; Miettunen J; Jääskeläinen E
    Eur Child Adolesc Psychiatry; 2024 Jun; 33(6):1741-1753. PubMed ID: 37568059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychotic patients who used cannabis frequently before illness onset have higher genetic predisposition to schizophrenia than those who did not.
    Aas M; Melle I; Bettella F; Djurovic S; Le Hellard S; Bjella T; Ringen PA; Lagerberg TV; Smeland OB; Agartz I; Andreassen OA; Tesli M
    Psychol Med; 2018 Jan; 48(1):43-49. PubMed ID: 28967348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early exposure to cannabis and risk for psychosis in young adolescents in Trinidad.
    Konings M; Henquet C; Maharajh HD; Hutchinson G; Van Os J
    Acta Psychiatr Scand; 2008 Sep; 118(3):209-13. PubMed ID: 18452569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistent Negative Symptoms in First-Episode Psychosis: Early Cognitive and Social Functioning Correlates and Differences Between Early and Adult Onset.
    Puig O; Baeza I; de la Serna E; Cabrera B; Mezquida G; Bioque M; Lobo A; González-Pinto A; Parellada M; Corripio I; Vieta E; Bobes J; Usall J; Contreras F; Cuesta MJ; Bernardo M; Castro-Fornieles J;
    J Clin Psychiatry; 2017; 78(9):1414-1422. PubMed ID: 28922588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stopping cannabis use benefits outcome in psychosis: findings from 10-year follow-up study in the PAFIP-cohort.
    Setién-Suero E; Neergaard K; Ortiz-García de la Foz V; Suárez-Pinilla P; Martínez-García O; Crespo-Facorro B; Ayesa-Arriola R
    Acta Psychiatr Scand; 2019 Oct; 140(4):349-359. PubMed ID: 31381129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [What support of young presenting a first psychotic episode, when schooling is being challenged?].
    Vacheron MN; Veyrat-Masson H; Wehbe E
    Encephale; 2017 Dec; 43(6):570-576. PubMed ID: 29128195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant salience in cannabis-induced psychosis: a comparative study.
    Ricci V; Di Muzio I; Ceci F; Di Carlo F; Mancusi G; Piro T; Paggi A; Pettorruso M; Vellante F; De Berardis D; Martinotti G; Maina G
    Front Psychiatry; 2023; 14():1343884. PubMed ID: 38260781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.